Skip to content

Effects of supplements on knee joint symptoms in healthy volunteers with knee joint symptoms.

Effects of supplements on knee joint symptoms in healthy volunteers with knee joint symptoms. - Effects of supplements on knee joint symptoms.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038289
Enrollment
48
Registered
2019-10-14
Start date
2020-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Ingestion of supplement-1 for 12 consecutive weeks. Ingestion of supplement-2 for 12 consecutive weeks. Ingestion of placebo for 12 consecutive weeks.

Sponsors

Pharma Foods International Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects who are adult male and female with subjective symptoms of knee joint pain. 2. Subjects who are classified into 0-I grade on the basis of the Kellgren-Lawrence classification (Subjects who undiagnosed with knee osteoarthritis by doctor). 3. Subjects who have agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Subjects with a history of treatment of malignant tumor, heart failure, myocardial infarction. 2. Subjects receiving treatment for the following chronic diseases, atrial fibrillation, arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, knee joint disease, other chronic diseases. 3. Subjects who routinely use medicines (including herbal medicine). 4. Subjects who are taking action to improve knee joint pain (including going to the hospital and treatment), and using medicines and health foods. 5. Subjects with allergies (medicine / test food related food). 6. Subjects who are planning to become pregnant or lactating. 7. Subjects who are judged as unsuitable for the study by doctor for other reasons.

Design outcomes

Primary

MeasureTime frame
JKOM, JOA

Secondary

MeasureTime frame
Knee joint subjective symptoms (VAS) Blood test (CTx-II, C2C, PIIANP)

Countries

Japan

Contacts

Public ContactMaya Sakashita

Pharma Foods International Co., Ltd. Research and Development Department

m-sakashita@pharmafoods.co.jp075-394-8605

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026